Jason Lettmann

Affiliations

  • Chief Executive Officer at Alx Oncology Holdings Inc (ALXO), 2025-04-15
  • Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2017-06-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALXO $11.31 4,400 $49,771.48 171,620 2024-03-14 Filing
ALXO $19.00 22,000 $418,000.00 22,000 2020-07-21 Filing
ALXO $19.00 378,000 $7,182,000.00 378,000 2020-07-21 Filing
RARX $13.00 15,633 $203,229.00 4,066,503 2016-10-31 Filing
RARX $13.00 114,752 $1,491,776.00 4,050,870 2016-10-31 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALXO $1.15 2,159 $2,483.28 170,270 2025-02-19 Filing
ALXO $30.23 60 $1,813.80 285,956 2021-12-13 Filing
ALXO $30.23 440 $13,301.20 2,097,326 2021-12-13 Filing
ALXO $29.60 181 $5,357.60 286,016 2021-12-13 Filing
ALXO $29.60 1,329 $39,338.40 2,097,766 2021-12-13 Filing